inlineVision Competitors

SenseTime is a leading AI software company focused on creating a better AI-empowered future through innovation. We are committed to advancing the state of the art in AI research, developing scalable and affordable AI software platforms that benefit businesses, people and society as a whole, while attracting and nurturing top talents to shape the future together. With our roots in the academic world, we invest in our original and cutting-edge research that allows us to offer and continuously improve industry-leading AI capabilities in universal multimodal and multi-task models, covering key fields across perception intelligence, natural language processing, decision intelligence, AI-enabled content generation, as well as key capabilities in AI chips, sensors and computing infrastructure. SenseTime’s business spans generative AI, vision AI, and innovative businesses. SenseTime advocates AI ethics from the "development" perspective. We have been actively involved in the development of national and international industry standards on data security, privacy protection, ethical and sustainable AI, working closely with multiple domestic and multilateral institutions on ethical and sustainable AI development. SenseTime was the only AI company in Asia to have its Code of Ethics for AI Sustainable Development selected by the United Nations as one of the key publication references in the United Nations Resource Guide on AI Strategies, and was published in June 2021. SenseTime Group Inc. has successfully listed on the Main Board of the Stock Exchange of Hong Kong Limited (HKEX). We have offices in markets including Hong Kong, Shanghai, Beijing, Shenzhen, Chengdu, Hangzhou, Xi’an, Singapore, Bangkok, Kuala Lumpur, Riyadh, Abu Dhabi, Dubai, and Seoul, etc., as well as presence in Germany, Thailand, Indonesia and the Philippines.

The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world's first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Acutus Medical is a dynamic arrhythmia care company focused on developing distinct, innovative technologies that provide physicians and patients with improved results. AcQMap, AcQRef and AcQGuide devices are CE Marked and FDA cleared. Please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.